Literature DB >> 1970666

CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.

A J Ulmer1, T Mattern, A C Feller, E Heymann, H D Flad.   

Abstract

In this study we investigated the binding of three different monoclonal antibodies (MoAb), TII 19-4-7, 4EL1C7, and B1.19.2, which are clustered in CD26 to the ectoenzyme dipeptidyl peptidase IV (DPP IV) and to T lymphocytes. We found that all three MoAb bind to both unstimulated and mitogen-stimulated T lymphocytes. Further results indicated an inconsistency within the CD26-clustered MoAb: TII 19-4-7 and 4EL1C7, but not B1.19.2, recognized DPP IV on the surface o T lymphocytes and immobilized on solid-phase ELISA or Western blot. There was competition of binding to DPP IV between TII 19-4-7 and 4EL1C7. From these results we conclude that CD26 antigen is represented by the ectoenzyme DPP IV. TII 19-4-7 and 4EL1C7 recognize the same or partly identical epitopes on DPP IV, whereas B1.19.2 recognizes a different antigen. TII 19-4-7 and 4EL1C7, but not B1.19.2, should be clustered in CD26.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970666     DOI: 10.1111/j.1365-3083.1990.tb02789.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  25 in total

1.  Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Authors:  J Wahlström; M Berlin; C M Sköld; H Wigzell; A Eklund; J Grunewald
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 2.  Innervation of the synovium.

Authors:  P I Mapp
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

3.  Placental villous stroma as a model system for myofibroblast differentiation.

Authors:  G Kohnen; S Kertschanska; R Demir; P Kaufmann
Journal:  Histochem Cell Biol       Date:  1996-06       Impact factor: 4.304

4.  Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.

Authors:  J Lin; P J Toscano; J T Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

Authors:  U Fiocco; M Rosada; L Cozzi; C Ortolani; G De Silvestro; A Ruffatti; E Cozzi; C Gallo; S Todesco
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

6.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Involvement of dipeptidyl peptidase IV in an in vivo immune response.

Authors:  T Kubota; G R Flentke; W W Bachovchin; B D Stollar
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 8.  The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV.

Authors:  R E Smith; C J Reynolds; E A Elder
Journal:  Histochem J       Date:  1992-09

9.  Identification of bile canalicular cell surface antigen HAM.4 as dipeptidyl peptidase IV (DPPIV) and characterization of its role in hepatic regeneration after partial hepatectomy in rats.

Authors:  M Tsugiki; Y Kobayashi; T Kawasaki; T Yoshimi
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

10.  Neuropeptide degrading enzymes in normal and inflamed human synovium.

Authors:  D A Walsh; P I Mapp; J Wharton; J M Polak; D R Blake
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.